JP2010506953A5 - - Google Patents

Download PDF

Info

Publication number
JP2010506953A5
JP2010506953A5 JP2009533511A JP2009533511A JP2010506953A5 JP 2010506953 A5 JP2010506953 A5 JP 2010506953A5 JP 2009533511 A JP2009533511 A JP 2009533511A JP 2009533511 A JP2009533511 A JP 2009533511A JP 2010506953 A5 JP2010506953 A5 JP 2010506953A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
compound
pharmaceutical composition
acceptable carrier
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009533511A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010506953A (ja
JP5343267B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/081685 external-priority patent/WO2008049027A1/en
Publication of JP2010506953A publication Critical patent/JP2010506953A/ja
Publication of JP2010506953A5 publication Critical patent/JP2010506953A5/ja
Application granted granted Critical
Publication of JP5343267B2 publication Critical patent/JP5343267B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009533511A 2006-10-17 2007-10-17 タラロゾール代謝物 Expired - Fee Related JP5343267B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85198906P 2006-10-17 2006-10-17
US60/851,989 2006-10-17
PCT/US2007/081685 WO2008049027A1 (en) 2006-10-17 2007-10-17 Talarazole metabolites

Publications (3)

Publication Number Publication Date
JP2010506953A JP2010506953A (ja) 2010-03-04
JP2010506953A5 true JP2010506953A5 (enExample) 2010-09-16
JP5343267B2 JP5343267B2 (ja) 2013-11-13

Family

ID=39314359

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009533511A Expired - Fee Related JP5343267B2 (ja) 2006-10-17 2007-10-17 タラロゾール代謝物

Country Status (10)

Country Link
US (2) US8188124B2 (enExample)
EP (1) EP2114895A4 (enExample)
JP (1) JP5343267B2 (enExample)
KR (1) KR101419965B1 (enExample)
CN (1) CN101611016B (enExample)
AU (1) AU2007311026B2 (enExample)
BR (1) BRPI0718310A2 (enExample)
CA (1) CA2667053C (enExample)
MX (1) MX2009004096A (enExample)
WO (1) WO2008049027A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9080145B2 (en) 2007-07-01 2015-07-14 Lifescan Corporation Single pluripotent stem cell culture
JP5769965B2 (ja) 2007-07-31 2015-08-26 ライフスキャン・インコーポレイテッドLifescan,Inc. ヒト胚性幹細胞の分化
CN101878298B (zh) 2007-11-27 2017-08-15 生命扫描有限公司 人胚胎干细胞的分化
KR101597731B1 (ko) 2008-02-21 2016-02-26 센토코 오르토 바이오테크 인코포레이티드 세포 부착, 배양 및 탈리를 위한 방법, 표면 개질 플레이트 및 조성물
AU2009267137A1 (en) 2008-06-30 2010-01-07 Centocor Ortho Biotech Inc. Differentiation of pluripotent stem cells
BRPI0919885A2 (pt) 2008-10-31 2015-08-11 Centocor Ortho Biotech Inc Diferenciação de células-tronco embrionárias humanas para a linhagem endócrina pancreática
KR102025158B1 (ko) 2008-10-31 2019-09-25 얀센 바이오테크 인코포레이티드 인간 배아 줄기 세포의 췌장 내분비 계통으로의 분화
PL2366022T3 (pl) 2008-11-20 2016-11-30 Sposoby i kompozycje do przyłączania i hodowli komórek na podłożach planarnych
JP2012509085A (ja) 2008-11-20 2012-04-19 ヤンセン バイオテツク,インコーポレーテツド マイクロキャリア上での多能性幹細胞の培養
AU2010276438B2 (en) 2009-07-20 2015-06-11 Janssen Biotech Inc. Differentiation of human embryonic stem cells
EP4410991A3 (en) 2009-12-23 2024-10-09 Janssen Biotech, Inc. Differentiation of human embryonic stem cells
KR20130025375A (ko) 2010-03-01 2013-03-11 얀센 바이오테크 인코포레이티드 만능 줄기 세포로부터 유래된 세포의 정제 방법
WO2011143299A2 (en) 2010-05-12 2011-11-17 Centocor Ortho Biotech Inc. Differentiation of human embryonic stem cells
WO2012030538A2 (en) 2010-08-31 2012-03-08 Janssen Biotech, Inc. Differentiation of human embryonic stem cells
PH12013500389A1 (en) 2010-08-31 2013-04-22 Janssen Biotech Inc Differentiation of human embryonic stem cells
PH12013500349A1 (en) 2010-08-31 2022-03-30 Janssen Biotech Inc Differentiation of pluripotent stem cells
US9248120B2 (en) 2011-08-23 2016-02-02 The Board Of Trustees Of The Leland Stanford Junior University Reversing intestinal inflammation by inhibiting retinoic acid metabolism
JP6441080B2 (ja) 2011-12-22 2018-12-19 ヤンセン バイオテツク,インコーポレーテツド 単一ホルモンのインスリン陽性細胞へのヒト胚性幹細胞の分化
JP6383292B2 (ja) 2012-03-07 2018-08-29 ヤンセン バイオテツク,インコーポレーテツド 多能性幹細胞の増殖及び維持のための明確な培地
MX358590B (es) 2012-06-08 2018-08-24 Janssen Biotech Inc Diferenciacion de celulas madre embrionarias humanas en celulas endocrinas pancreaticas.
US10370644B2 (en) 2012-12-31 2019-08-06 Janssen Biotech, Inc. Method for making human pluripotent suspension cultures and cells derived therefrom
JP6557147B2 (ja) 2012-12-31 2019-08-07 ヤンセン バイオテツク,インコーポレーテツド Hb9調節物を用いたヒト胚性幹細胞の膵臓内分泌細胞への分化
EP2938722B1 (en) 2012-12-31 2021-12-08 Janssen Biotech, Inc. Suspension and clustering of human pluripotent cells for differentiation into pancreatic endocrine cells
SG10201709338RA (en) 2012-12-31 2017-12-28 Janssen Biotech Inc Culturing of human embryonic stem cells at the air-liquid interface for differentiation into pancreatic endocrine cells
CN117821369A (zh) 2014-05-16 2024-04-05 詹森生物科技公司 小分子增强胰腺内分泌细胞中的mafa表达的用途
MA45479A (fr) 2016-04-14 2019-02-20 Janssen Biotech Inc Différenciation de cellules souches pluripotentes en cellules de l'endoderme de l'intestin moyen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100365312B1 (ko) * 1996-06-27 2003-03-06 얀센 파마슈티카 엔.브이. N-[4-(헤테로아릴메틸)페닐]헤테로아릴아민
AP869A (en) * 1998-01-05 2000-09-04 Pfizer 2,3-Substituted indole compounds as anti-inflammatory and analgesic agents.
MXPA04005864A (es) * 2001-12-19 2004-10-29 Atherogenics Inc Derivados de charcona y su uso para tratar enfermedades.
US20060205945A1 (en) * 2004-05-14 2006-09-14 Pfizer Inc Pyrimidine derivatives for the treatment of abnormal cell growth
PL372356A1 (pl) * 2005-01-20 2006-07-24 ADAMED Sp.z o.o. Nowe związki, pochodne kwasu 3-fenylopropionowego
TW200639163A (en) * 2005-02-04 2006-11-16 Genentech Inc RAF inhibitor compounds and methods

Similar Documents

Publication Publication Date Title
JP2010506953A5 (enExample)
JP2006514931A5 (enExample)
EP2396081B1 (en) Alkylamido compounds and uses thereof
JP2009519993A5 (enExample)
JP2007530523A5 (enExample)
JP2009502743A5 (enExample)
JP2010530373A5 (enExample)
JP2013515006A5 (enExample)
JP2010001302A5 (enExample)
JP2006523197A5 (enExample)
JP2007511546A5 (enExample)
JP2010506953A (ja) タラロゾール代謝物
BRPI0408492A (pt) processo para preparar ditioésteres
JP2009543799A5 (enExample)
JP2007515465A5 (enExample)
CA2595544A1 (en) Compounds having analgesic and/or immunostimulant activity
JP2013523623A5 (enExample)
BRPI0518647A2 (pt) processo para a produÇço de um composto, e, composto
JP2014530818A5 (enExample)
JP2007502832A5 (enExample)
EA022994B1 (ru) Способ подавления толерантности к опиоидному анальгетику
JP2018145180A5 (enExample)
JP2004502684A5 (enExample)
JP2010209099A5 (enExample)
CN114302883A (zh) Vmat2抑制剂及其制备方法和应用